Regular screening of faeces for blood can detect colorectal cancer earlier and hence may reduce mortality in populations at risk, such as older patients. The screening test used in these trials to detect colorectal (bowel) cancer was the faecal occult blood test (FOBT). If the FOBT is positive, the bowels are examined closely with further diagnostic test (coloscopy, flexible sigmoidoscopy, double-contrast barium enema), but these tests often cause discomfort and can cause serious adverse consequences. As blood identified in faeces may be due to several reason (unrelated to cancer), it may cause people unnecessary stress and expose them to possible harm. This review found that FOBT screening is likely to avoid approximately 1 in 6 colorectal cancer deaths.
Screening for colorectal cancer using the faecal occult blood test, Hemoccult
16 February 2011
This record should be cited as:
Hewitson P, Glasziou PP, Irwig L, Towler B, Watson E. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD001216. DOI: 10.1002/14651858.CD001216.pub2
Assessed as up to date:
7 June 2010
More like this
- Prophylactic anastomotic drainage for colorectal surgery
- Guaiac-based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average-risk individuals
- Chromoscopic colonoscopy enhances polyp detection compared with conventional colonoscopy
- Short-term benefits for laparoscopic colorectal resection
- The use of hyaluronic acid/carboxymethyl cellulose (HA/CMC) membrane, reduces the incidence, extent and severity of adhesions in the abdomen.